-+ 0.00%
-+ 0.00%
-+ 0.00%

X4 Pharmaceuticals shareholders approved amended 2017 equity incentive plan share increase

PUBT·05/12/2026 20:24:39
Listen to the news
X4 Pharmaceuticals shareholders approved amended 2017 equity incentive plan share increase
  • X4 Pharmaceuticals held its annual meeting on March 20, 2026.
  • Stockholders authorized an increase of 1,500,000 shares available for issuance under Second Amended and Restated 2017 Equity Incentive Plan; authorization does not by itself indicate any shares have been issued.
  • PricewaterhouseCoopers was ratified as independent registered public accounting firm for year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001501697-26-000047), on May 12, 2026, and is solely responsible for the information contained therein.